We are live on ! Find out more
SCM

Symons Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 9.32%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+9.32%
3 Year Est. Return
+25.41%
5 Year Est. Return
+28.46%
10 Year Est. Return
–
AUM
$369M
AUM Growth
+$1.57M
Cap. Flow
+$420K
Cap. Flow %
0.11%
Top 10 Hldgs %
50.53%
Holding
91
New
20
Increased
19
Reduced
30
Closed
22

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$19.6M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.2M
3
CAG icon
Conagra Brands
CAG
+$15.9M
4
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
+$14.3M
5
TGT icon
Target
TGT
+$10.2M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$24.2M
2
DUK icon
Duke Energy
DUK
+$18.5M
3
SO icon
Southern Company
SO
+$13.1M
4
PPL
PPL Corp
PPL
+$9.29M
5
GFI icon
Gold Fields
GFI
+$9.08M

Sector Composition

Rank Sector Weight
1 Consumer Staples 49.17%
2 Healthcare 18.5%
3 Technology 12.87%
4 Industrials 6.3%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
1
Procter & Gamble
PG
$340B
$21.7M 5.89%
287,470
+2,750
+1% +$219K
PM icon
2
Philip Morris
PM
$309B
$21.4M 5.8%
247,236
-4,560
-2% -$399K
ORCL icon
3
Oracle
ORCL
$339B
$20M 5.42%
+602,680
New +$19.6M
NOC icon
4
Northrop Grumman
NOC
$76B
$20M 5.42%
209,757
+1,200
+0.6% +$111K
TGT icon
5
Target
TGT
$66.3B
$19.1M 5.18%
298,763
+149,853
+101% +$10.2M
CPB icon
6
Campbell Soup
CPB
$6.85B
$19M 5.14%
465,962
-5,090
-1% -$228K
TEVA icon
7
Teva Pharmaceuticals
TEVA
$40.4B
$18.6M 5.04%
+492,195
New +$19.2M
ESRX
8
DELISTED
Express Scripts Holding Company
ESRX
$15.7M 4.25%
253,795
+2,890
+1% +$187K
TAP icon
9
Molson Coors Class B
TAP
$8.02B
$15.5M 4.19%
308,598
-2,205
-0.7% -$111K
MSFT icon
10
Microsoft
MSFT
$2.9T
$15.5M 4.19%
464,377
+149,385
+47% +$4.91M
HAS icon
11
Hasbro
HAS
$13.5B
$15.1M 4.09%
319,886
-1,405
-0.4% -$65.6K
ABV
12
DELISTED
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
$15M 4.06%
+390,445
New +$14.3M
PEP icon
13
PepsiCo
PEP
$196B
$14.9M 4.04%
187,408
-1,092
-0.6% -$89.7K
T icon
14
AT&T
T
$164B
$14.2M 3.86%
557,027
+7,070
+1% +$186K
AMGN icon
15
Amgen
AMGN
$209B
$14.2M 3.85%
126,757
-67,440
-35% -$7.31M
MDLZ icon
16
Mondelez International
MDLZ
$82.9B
$14.1M 3.83%
449,655
-11,240
-2% -$349K
CAG icon
17
Conagra Brands
CAG
$7.42B
$13.9M 3.78%
+589,828
New +$15.9M
HSY icon
18
Hershey
HSY
$37.3B
$12.9M 3.49%
139,189
-1,430
-1% -$133K
K
19
DELISTED
Kellanova
K
$10.1M 2.73%
182,551
-372
-0.2% -$22.2K
NVO
20
Novo Nordisk
NVO
$228B
$9.95M 2.7%
+588,070
New +$9.89M
GSK icon
21
GSK
GSK
$107B
$9.84M 2.67%
156,872
-2,828
-2% -$182K
GLW icon
22
Corning
GLW
$107B
$9.26M 2.51%
+634,769
New +$9.4M
KRFT
23
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$5.56M 1.51%
105,914
+1,442
+1% +$79K
SBSW icon
24
Sibanye-Stillwater
SBSW
$6.05B
$1.3M 0.35%
265,791
-2,864
-1% -$10.5K
NSR
25
DELISTED
Neustar Inc
NSR
$1.09M 0.29%
21,975
-200
-0.9% -$10.4K
1
2 3 4

Similar funds

SVC
Strycker View Capital New York $156M AUM 73.52% 1-Year Est. Return
RP
RBS Partners Bay Harbor Islands, Florida $155M AUM 153.45% 1-Year Est. Return
KGA
KPCB GGF Associates Menlo Park, California $157M AUM
BRC
BHF RG Capital Scottsdale, Arizona $150M AUM 18.4% 1-Year Est. Return
NWS
Newport Wealth Strategies Irvine, California $165M AUM 24.55% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
FWM
Filbrandt Wealth Management Middleton, Wisconsin $174M AUM 35.59% 1-Year Est. Return
DP
DSAM Partners London, United Kingdom $176M AUM 83.78% 1-Year Est. Return

Symons Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Symons Capital Management held 91 positions worth $369M, up 0.43% from $367M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Symons Capital Management's Q3 2013 filing shows 20 new, 19 increased, 30 reduced and 22 closed positions. Its largest new stake was Oracle: 602,680 shares worth $20M. The largest sale was CVS Health, an estimated $24.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 49% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Symons Capital Management's largest Q3 2013 buy was Oracle: 602,680 shares worth $20M.
  • Symons Capital Management added most to Target in Q3 2013, an estimated $10.2M increase.
  • Symons Capital Management's biggest Q3 2013 reduction was Amgen, cutting an estimated $7.31M.
  • Symons Capital Management fully exited CVS Health in Q3 2013, selling an estimated $24.2M.
  • Symons Capital Management's ten largest holdings make up 51% of its $369M portfolio in Q3 2013.
  • Symons Capital Management opened 20 new positions and closed 22 in Q3 2013.
  • Symons Capital Management's portfolio value rose 0.43% quarter-over-quarter to $369M.

Based on Symons Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.